A practical research guide to peptide purity testing, HPLC chromatograms, mass spectrometry identity checks, and the COA details that matter before a compound enters a protocol.

Purity is one of the simplest variables to name and one of the easiest variables to underestimate. In peptide research, a vial is not only a label and a nominal weight. It is a mixture that needs to be characterized before it can be treated as a controlled input. The tighter the protocol, the more important that characterization becomes.
High performance liquid chromatography and mass spectrometry answer two different questions. HPLC estimates how much of the detected material behaves like the target compound. Mass spectrometry checks whether the dominant material has the molecular weight expected from the stated peptide sequence. Together, they help researchers separate a credible batch from a batch that could add noise to an experiment.
Peptides are assembled step by step. Missed couplings, truncated chains, protecting group remnants, salts, solvents, oxidation products, and degradation fragments can all remain after synthesis and purification. Some impurities are biologically inert. Others may compete for receptors, change solubility, alter pH, or shift apparent potency.
A reported purity value is therefore not cosmetic. It is a statement about experimental control. If a compound is listed at 95 percent purity, the remaining five percent is still material present in the system. For mechanistic work, that remainder can matter.
In HPLC testing, the sample is carried through a column and separated by chemical interaction with the column material. The detector produces a chromatogram: a series of peaks appearing at different retention times. A clean peptide batch should show one dominant target peak and only small secondary peaks.
The area under each peak is used to estimate relative abundance. If the target peak accounts for 99 percent of the total integrated peak area, the sample is commonly reported as 99 percent pure by HPLC. This does not prove identity by itself, but it is a strong indication of chromatographic cleanliness.
Mass spectrometry complements HPLC by measuring mass-to-charge signals from ionized molecules. For peptide work, the observed mass is compared with the theoretical molecular weight calculated from the amino acid sequence and expected salt or terminal modifications.
This is the identity check. A sample can produce a clean HPLC chromatogram and still be the wrong compound if the wrong sequence was synthesized or mislabeled. Matching the theoretical and observed mass reduces that risk.
A Certificate of Analysis should connect the test result to the actual batch in hand. The most useful COAs include the compound name, sequence or molecular formula, lot number, test date, HPLC purity, mass spectrometry result, and the name of the laboratory performing the analysis.
A missing COA is the clearest warning sign. Other concerns include undated documents, no lot number, purity claims without method data, unusually high purity claims with no chromatogram, or identity testing that is absent from the report.
For serious research, purity standards should be chosen before purchase and documented in the protocol. Many labs use 98 percent as a minimum screening threshold and prefer 99 percent or higher for sensitive mechanistic studies.
HPLC and mass spectrometry are not interchangeable. HPLC helps quantify sample cleanliness. Mass spectrometry helps verify molecular identity. A strong peptide sourcing workflow uses both, reviews the COA before the compound enters a protocol, and keeps batch documentation tied to the resulting data.
Titan Labs supplies research materials for laboratory use only. They are not intended for human or veterinary consumption, diagnosis, treatment, or any non-research application.
Continue exploring
Browse All Research